Johnson John Paul 4
4 · Evolent Health, Inc. · Filed Feb 26, 2024
Insider Transaction Report
Form 4
Johnson John Paul
Chief Financial Officer
Transactions
- Award
Class A Common Stock
2024-02-22+44,000→ 244,016 total - Tax Payment
Class A Common Stock
2024-02-22$33.03/sh−20,006$660,798→ 224,010 total
Footnotes (3)
- [F1]Represents the number of shares received upon the settlement of the second tranche of performance-based share units (PSUs) awarded to the reporting person on March 1, 2021, following the certification of achievement of specified performance metrics. The shares underlying the second tranche of the PSU award vested at the conclusion of the performance period on December 31, 2023.
- [F2]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
- [F3]This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of performance stock units.